Dr. Kristen Kroll received a five-year R01 research grant

Dr. Kristen Kroll received a five-year R01 research grant
Dr. Kristen Kroll, Ph.D., Associate Professor of Developmental Biology received a five-year $3,631.263  R01 research grant from the National Institutes of Health, National Institute of Mental Health beginning December 1, 2020, for her project entitled “Genomic and functional characterization of ASD and ID-associated MYT1L mutation”.

Dr. Dave Ornitz has received a two-year, grant award from Eli Lily & Co

Dr. Dave Ornitz has received a two-year, grant award from Eli Lily & Co
Congratulations to Dr. David Ornitz! David M. Ornitz, M.D., Ph.D., Alumni Endowed Professor of Developmental Biology has received a two-year, $265,000 grant award from Eli Lily & Co. (LRP) beginning December 1, 2020, for his project entitled “Effects of endothelial FGF signaling on myocardial dysfunction in a mouse model of heart failure with preserved ejection […]

Dr. Shin-ichiro Imai has received a two-year research grant from WUCATR

Dr. Shin-ichiro Imai has received a two-year research grant from WUCATR
Congratulations to Dr. Shin Imai! Dr. Shin-ichiro Imai, M.D., Ph.D., Professor of Developmental Biology has received a two-year $300,000 research grant from WUCATR – WashU Center for Autophagy Therapeutics and Research beginning December 1, 2020, for his project entitled “Elucidating the functional connection between NAD+ metabolism and autophagy in metabolism and aging”

Dr. Morris has received an award starting on January 1, 2021

Dr. Morris has received an award starting on January 1, 2021
Samantha A. Morris, Assistant Professor of Developmental Biology and of Genetics, has received a five-year, $1,500,000, New York Stem Cell Foundation Robertson Stem Cell Investigator Award starting on January 1, 2021, for her project entitled “New single-cell genomic technologies to dissect and enhance cell fate reprogramming”.

Startup company founded by WU scientists acquired by Eli Lilly

Startup company founded by WU scientists acquired by Eli Lilly
“Pharmaceutical maker Eli Lilly and Company has purchased Disarm Therapeutics, a startup biotechnology firm founded by researchers at Washington University School of Medicine in St. Louis. Disarm Therapeutics was co-founded by Jeffrey Milbrandt, MD, PhD, and Aaron DiAntonio, MD, PhD, to speed the development of treatments for multiple neurodegenerative conditions.” Congratulations to Dr. Aaron DiAntonio! […]

Dr. Rentschler was selected to be funded by Additional Ventures

Dr. Rentschler was selected to be funded by Additional Ventures
Congratulations Dr. Stacey Rentschler! Dr. Rentschler has been selected as one of 8 multi-disciplinary investigators to be funded by Additional Ventures to work together towards a cure for single ventricle heart disease using regenerative medicine approaches. Additional Ventures has committed $2 million per year for 5 years to fund this initiative.

Dr. Tony Tsai will be joining the Department on January 1st

Dr. Tony Tsai will be joining the Department on January 1st
Dr. Tony Tsai will be joining the Department on January 1st, 2021! “Trained as a systems developmental biologist, I am fascinated by the striking robustness of embryo development. Despite environmental fluctuations and the stochastic nature of instructive signals, cells generate tissue-scale patterns and structures in a precise and reproducible fashion. My lab aims to understand […]